DUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Wednesday reported first-quarter earnings of $69.4 million.
The Dublin-based company said it had profit of $1.04 per share. Earnings, adjusted for one-time gains and costs, were $3.95 per share.
The results did not meet Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $4.26 per share.
The drugmaker posted revenue of $892.8 million in the period, also missing Street forecasts. Nine analysts surveyed by Zacks expected $898.1 million.
Jazz expects full-year earnings in the range of $16.90 to $17.85 per share, with revenue in the range of $3.68 billion to $3.88 billion.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.